Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Smurfit Kappa GP Director's Dealing 2020

Apr 17, 2020

1952_dirs_2020-04-17_c1c02e3e-ec7e-4997-bbe8-4568085c675e.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0491K

Smurfit Kappa Group PLC

17 April 2020

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Anne Anderson

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial Notification Amendment

Initial Notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Smurfit Kappa Group plc

b)

LEI

635400CPLP8H5ITDVT56

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type  of instrument

Identification code

Ordinary Shares of €0.001 each

IE00B1RR8406

b)

Nature of the transaction  

1.     Acquisition of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
1.     €  25.90 3,668

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

16 April 2020

f)

Place of the transaction

Dublin, Ireland

g)

Additional Information

N/A

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBGGDSUBBDGGR